Firma Immungenetics, Autor bei PR-Web

Immungenetics AG: Last Patient Last Visit (LPLV) reached in first part of the DrainAD Study, a Phase 2 trial for the early diagnosis and causative treatment of Alzheimer’s Disease (AD)

Posted on 13. June 201814. December 2020 by Firma Immungenetics Posted in Research / Development Tagged alzheimer's, amyloid, attack, beta, brain, immungenetics, interim, labs, mice, mining, new, patients, rostock, thiethylperazine, with

Immungenetics AG, a German based biopharmaceutical company focusing on novel treatments for unmet medical needs in the field of neurodegenerative, autoimmune diseases and aging, announced today that the last study visit of the last patient enrolled (Last Patient’s Last Visit, LPLV) […]